Complex systems applied? The merger that made Glaxo SmithKline

Technology Analysis and Strategic Management

Volumn 14, Issue 3, 2002, Pages 331-354

  Randles, Sally ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INDUSTRIAL PRACTICE; MERGER; PHARMACEUTICAL INDUSTRY;

EID: 0036723658     PISSN: 09537325     EISSN: None     Source Type: Journal    
DOI: 10.1080/0953732022000002140     Document Type: Article

References (50)

1. Services and systems of innovation
2. Mega-mergers in the pharmaceutical industry: A strategy or fad?
3. Complex systems and the merger process
4. Mergers, MNES and innovation- The need for new research approaches
5. Merger motives and merger prescriptions
6. Global-local tensions: Firms and States in the global space-economy
7. Distributed innovations systems and instituted economic processes
8. Economic diversity as cement and as a challenge to evolutionary perspectives
9. Evolution and inter-creation: The government-business-society nexus
10. Case study: The NOVARTIS mega-merger: An intra-organisational evolutionary perspective
11. Strategic evolution in highly complex realities: Corporate level strategy in the situation of merger
12. Knowledge, understanding and the epistemology of innovating firms
13. Introduction
14. Technology, work restructuring and the orchestration of a rational narrative in the pursuit of "management objectives": The political process of plant-level change
15. The social construction of facts and artefacts: Or how the sociology of science and the sociology of technology might benefit each other
16. The economy as instituted process
17. How the object of knowledge constrains knowledge of the object. An epistemological analysis of a social research investigation
18. Technical change and the theory of "regulation"
19. The variety and unequal performance of really existing markets: Farewell to Doctor Pangloss?
20. Systems of innovation in an era of globalisation
21. What is a market? On the methodology of a contested concept
22. Competition as instituted economic process
23. Market exchanges and instituted economic process
24. Economic integration and practical consumption: Some theoretical considerations
25. Between demand and consumption: A framework for research
26. Innovation and competition in UK supermarkets
27. Turnkey production networks: A new American model of industrial organisation?
28. Innovation and merger decisions in the pharmaceutical industry
29. A CEO roundtable on making mergers succeed
30. Cross-atlantic consolidation gains pace
31. Technological powerhouse or diluted competence: Techniques for assessing mergers via patent analysis
32. Drugs groups need to re-learn some harsh commercial lessons
33. The pharmaceutical industry